p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene

Cancer Research

Volumn 57, Issue 20, 1997, Pages 4474-4477

  Agani, Faton ^a   Kirsch, David G ^a   Friedman, Scott L ^b   Kastan, Michael B ^a   Semenza, Gregg L ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b the Liver Center   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; TUMOR BLOOD FLOW;

CARCINOMA, HEPATOCELLULAR; CELL HYPOXIA; CLONE CELLS; ENDOTHELIAL GROWTH FACTORS; GENES, REPORTER; HUMANS; LIVER NEOPLASMS; LYMPHOKINES; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030767287     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
2. Forsythe, J. A., Jiang, B-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol., 16: 4604-4613, 1996.
3. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
4. Ferrara, N., and Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev., 18: 4-25, 1997.
5. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature (Lond.), 379: 88-91, 1996.
6. Mukhopadhyay, D., Tsiokas, L., and Sukhatme, V. P. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res., 55: 6161-6165, 1995.
7. Grand, R. J., Lecane, P. S., Owen, D., Grant, M. L., Roberts, S., Levine, A. J., and Gallimore, P. H. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression. Virology, 210: 323-334, 1995.
8. Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J., and Livingston, D. M. Binding and modulation of p53 by p300/CBP coactivators. Nature (Lond.), 387: 823-827, 1997.
9. Querido, E., Marcellus, R. C., Lai, A., Charbonneau, R., Teodora, J. G., Ketner, G., and Branton, P. E. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol., 71: 3788-3798, 1997.
10. Samasundaram, K., and El-Deiry, W. S. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene, 14: 1047-1057, 1997.
11. Friedman, S. L., Shaulian, E., Littlewood, T., Resnitzky, D., and Oren, M. Resistance to p53-mediated growth arrest and apoptosis in Hep3B hepatoma cells. Oncogene, 15: 63-70, 1997.
12. Vater, C. A., Bartle, L. G., Dionne, C. A., Littlewood, D. T., and Goldmacher, V. S. Induction of apoptosis by tamoxifen activation of p53-estrogen receptor fusion protein expressed in E1A and T24 H-ras-transformed p53-/-mouse embryo fibroblasts. Oncogene, 13: 739-748, 1996.
13. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., and Vogelstein, B. Suppresion of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
14. Kastan, M. B., Zhan, Q., El-Dairy, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, J. A., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and gadd45 is defective in ataxia telangiectasia. Cell, 71: 587-597, 1992.
15. Wang, G. L., and Semenza, G. L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem., 270: 1230-1237, 1995.
16. Bressac, B., Galvin, K. M., Liang, T. J., Isselbacher, K. J., Wands, J. R., and Ozturk, M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 87: 1973-1977, 1990.
17. Semenza, G. L., Jiang, B-H., Leung, S. W., Passantino, R., Concordet, J-P., Maire, P., and Giallongo, A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem., 271: 32529-32537, 1996.
18. Kieser, A., Weich, H. A., Brandner, G., Marme, D., and Kolch, W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene, 9: 963-969, 1994.
19. Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science (Washington DC), 265: 1582-1584, 1994.
20. Van Meir, E. G., Polverini, P. J., Chazin, V. R., Huang, H-J. S., de Tribolet, N., and Cavenee, W. K. Release of an inhibitor of angiogenesis upon induction of wild-type p53 expression in glioblastoma cells. Nat. Genet., 8: 171-176, 1994.